Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2016
A Faropenem, Linezolid, and Moxifloxacin Regimen for Both Drug-Susceptible and Multidrug-Resistant Tuberculosis in Children: FLAME Path on the Milky WayDevyani Deshpande, Shashikant Srivastava, Eric Nuermberger, et al.
Antimicrobial Agents and Chemotherapy|November 10, 2020
Differential In Vitro Activities of Individual Drugs and Bedaquiline-Rifabutin Combinations against Actively Multiplying and Nutrient-Starved Mycobacterium abscessusJin Lee, Nicole Ammerman, Anusha Agarwal, et al.
American Journal of Respiratory and Critical Care Medicine|December 23, 2021
Efficacy of Long-Acting Bedaquiline Regimens in a Mouse Model of Tuberculosis Preventive TherapyAmit Kaushik, Nicole C Ammerman, Rokeya Tasneen, et al.
American Journal of Respiratory and Critical Care Medicine|September 10, 2005
Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse modelEric Nuermberger, Sandeep Tyagi, Kathy N Williams, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2018
The Sterilizing Effect of Intermittent Tedizolid for Pulmonary TuberculosisShashikant Srivastava, Devyani Deshpande, Eric Nuermberger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2016
A Combination Regimen Design Program Based on Pharmacodynamic Target Setting for Childhood Tuberculosis: Design Rules for the PlaygroundShashikant Srivastava, Devyani Deshpande, Jotam G Pasipanodya, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2015
Selective Inactivity of Pyrazinamide against Tuberculosis in C3HeB/FeJ Mice Is Best Explained by Neutral pH of CaseumJean-Philippe Lanoix, Thomas Ioerger, Aimee Ormond, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2008
Powerful bactericidal and sterilizing activity of a regimen containing PA-824, moxifloxacin, and pyrazinamide in a murine model of tuberculosisEric Nuermberger, Sandeep Tyagi, Rokeya Tasneen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2016
Linezolid for Infants and Toddlers With Disseminated Tuberculosis: First StepsDevyani Deshpande, Shashikant Srivastava, Jotam G Pasipanodya, et al.
Annual Review of Pharmacology and Toxicology|August 19, 2020
Development of New Tuberculosis Drugs: Translation to Regimen Composition for Drug-Sensitive and Multidrug-Resistant TuberculosisJacqueline P Ernest, Natasha Strydom, Qianwen Wang, et al.
Pageof 8